Mark Chasin

This inventor holds 80 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Formulations (CPC class 424468). Top assignees: Euro-Celtique S.a., Purdue Pharma L.p., Euroceltigue, S.a.. Active years: 1993-2018.

USPTO Granted Patents = 80 (Patent Applications = 1)

% Patents Active = 88.8

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 43

Forward Citations = 11,200(Granted Patents)

Forward Citations (Not Self Cited) = 11,042(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Manalpan, NJ (US) (1993 - 1997)
Manalapan, NJ (US) (1993 - 2009)
Manapalan, NJ (US) (2015)
Monroe, NJ (US) (2018)

Company Filing History:

Years Active: 1993-2018

Loading Chart...

Areas of Expertise:

Pharmaceutical Products

Controlled Release

Opioid Formulations

Melt-Extrusion

Prolonged Anesthesia

Aqueous Dispersions

Sustained Release

PDE IV Inhibition

Hydrophobic Polymer

Multiparticulates

Purine Derivatives

Tramadol Formulations

80 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10092519 - Pharmaceutical products (2018-10-09),

2. 9149436 - Pharmaceutical product comprising a sequestered agent (2015-10-06),

3. 7510727 - Melt-extrusion multiparticulates (2009-03-31),

4. 7316821 - Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer (2008-01-08),

5. 7270831 - Orally administrable opioid formulations having extended duration of effect (2007-09-18),

6. 7070806 - Controlled release formulations coated with aqueous dispersions of acrylic polymers (2006-07-04),

7. 6921541 - Formulations and methods for providing prolonged local anesthesia (2005-07-26),

8. 6905709 - Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer (2005-06-14),

9. 6743442 - Melt-extruded orally administrable opioid formulations (2004-06-01),

10. 6706281 - Melt-extrusion multiparticulates (2004-03-16),

11. 6699908 - Methods for providing safe local anesthesia (2004-03-02),

12. 6645527 - Stabilized sustained release tramadol formulations (2003-11-11),

13. 6572885 - Orally administrable opioid formulations having extended duration of effect (2003-06-03),

14. 6534081 - Prolonged anesthesia in joints and body spaces (2003-03-18),

15. 6524607 - Formulations and methods for providing prolonged local anesthesia (2003-02-25),

Title: The Innovative Journey of Mark Chasin

Introduction: Mark Chasin, a distinguished inventor hailing from Manalapan, NJ (US), has made significant contributions to the world of innovations with his creative mind and relentless pursuit of excellence.

Latest Patents: Mark Chasin holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on cutting-edge advancements in renewable energy solutions and smart home devices.

Career Highlights: Throughout his illustrious career, Mark Chasin has been recognized for his groundbreaking inventions that have revolutionized industries. His innovative spirit and dedication to pushing the boundaries of technology have earned him a reputation as a visionary inventor.

Collaborations: Mark Chasin has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has led to the successful development and commercialization of his innovative ideas.

Conclusion: In conclusion, Mark Chasin stands as a beacon of creativity and ingenuity in the world of inventions. His passion for innovation and commitment to making a positive impact on society continue to inspire aspiring inventors around the globe.